If you dont alter or change your lifestyle then once you stop them you will end up right where you started
Healthcare professionals may prescribe metformin alongside GLP-1 medication
Early Clinical Trials : Some small and early-stage clinical trials and pilot studies have suggested that GLP-1 receptor agonists might improve glycemic control and reduce insulin doses in T1D patients, adding a layer of support for the proposed therapeutic approaches
Tapering Considerations: Gradually reduce GLP-1 dosing while increasing fiber and protein intake Begin nutraceutical support (e.g., berberine, chromium) 24 weeks prior to taper Monitor lean mass and glycemic variability Support appetite signaling with mindful eating and circadian regulation Address gut motility and emotional eating patterns with botanical support Clinical Example: A Case in Practice A 52-year-old female on semaglutide for 6 months presented with nausea, fatigue, and concern about lean mass loss
At least a first TLR agonist may also be operatively attached to a human antibody of the invention to create a therapeutic conjugate, as described herein in the immunoconjugate section
Everybody responds differently
